Methods and Related Kits for Treating and Regenerating Tooth Pulp and Periapical Tissues in a Mammal
US-2018161394-A1 · Jun 14, 2018 · US
Same day single visit damaged tooth treatment method
US11324568B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11324568-B2 |
| Application number | US-202117389478-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 30, 2021 |
| Priority date | Sep 12, 2019 |
| Publication date | May 10, 2022 |
| Grant date | May 10, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to the application of a composition containing recombinant amelogenin and propylene glycol alginate (“PGA”) on to cut dentin tubules followed by installation of a definitive restorative in a single visit.
First claim
Opening claim text (preview).
The invention claimed is: 1. A same day single visit method for capping a damaged tooth, comprising: applying a treatment composition comprising amelogenin and propylene glycol alginate (“PGA”) to a surface of exposed pulp of the damaged tooth; then capping the damaged tooth by applying a permanent dental restorative on top of the treatment composition present on the exposed pulp, wherein the treatment composition comprises 30 mg amelogenin protein powder in mixture with 1 ml of a combination of propylene glycol alginate and a saline matrix. 2. The method of claim 1 , wherein the amelogenin comprises an amino acid sequence that is at least 95% identical to the amino acid sequence of SEQ ID NO: 2, 4 or 6 or a sequence that has at least 95% sequence identity to SEQ ID NOS: 2, 4 or 6 or a fragment thereof having at least 30 contiguous amino acid residues. 3. The method of claim 1 , wherein the treatment composition consists essentially of recombinant human amelogenin, the saline and the propylene glycol alginate. 4. The method of claim 1 , wherein the treatment composition further comprises a remineralization agent selected from the group consisting of a material providing calcium ions, a material providing phosphorous ions, and a material providing fluoride ions. 5. The method of claim 1 , wherein the subject is suffering from amelogenesis imperfecta.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11324568B2 cover?
- The invention relates to the application of a composition containing recombinant amelogenin and propylene glycol alginate (“PGA”) on to cut dentin tubules followed by installation of a definitive restorative in a single visit.
- Who is the assignee on this patent?
- Univ King Abdulaziz
- What technology area does this patent fall under?
- Primary CPC classification A61K6/56. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).